Clinical Trials Logo

Rectal Cancer clinical trials

View clinical trials related to Rectal Cancer.

Filter by:

NCT ID: NCT04357171 Completed - Rectal Cancer Clinical Trials

PReventive cOlostomy vs Ileostomy in Low anTErior reCTal Resection

PROTECT
Start date: January 14, 2012
Phase: N/A
Study type: Interventional

The type of preventive intestinal stoma (colostomy/ileostomy) after low anterior rectal resection rectum is still a debate. This study purpose is to demonstrate that preventive loop ileostomy is characterized by a higher readmission rate caused by dehydration, in comparison with the loop colostomy.

NCT ID: NCT04340401 Recruiting - Rectal Cancer Clinical Trials

Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

Start date: May 25, 2020
Phase: Phase 2
Study type: Interventional

This study is designed to test the efficacy and safety of Total Neoadjuvant Treatment plus SHR1210(an anti-PD-1 Inhibitor) for High-risk locally advanced Rectal Cancer, Meanwhile, screening effective Biomarker base on neoantigen.

NCT ID: NCT04339374 Recruiting - Rectal Cancer Clinical Trials

Ultrasound and Photoacoustic Imaging of Colon and Rectal Tumor Tissue

Start date: July 19, 2017
Phase:
Study type: Observational

The purpose of this pilot study is to a) explore the photoacoustic properties of normal, polypoid, and malignant colorectal tissue and b) demonstrate the functionality of a novel endorectal photoacoustic ultrasound probe in humans with rectal cancer. The study includes two parts. The initial exploratory portion will be conducted ex vivo with resected colon and rectal specimens immediately following surgical excision. Based on those findings, an endorectal probe will then be constructed to examine in vivo tumors. The investigators hypothesize that in vivo photoacoustic imaging will be capable of differentiating normal from malignant tissue.

NCT ID: NCT04336202 Recruiting - Rectal Cancer Clinical Trials

Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy

Whistle
Start date: August 2024
Phase: N/A
Study type: Interventional

Within our institution, the principal investigator have acquired expertise in endorectal brachytherapy, a localized treatment for colorectal cancer. Until now a modality which uses an endorectal applicator has been used, which has certain limitations. In the context of this study, a new applicator will be used which is already approved by Health Canada for endorectal brachytherapy, thereby improving the participant's quality of life and optimizing treatment time.

NCT ID: NCT04334421 Completed - Rectal Cancer Clinical Trials

APEMESH- Preventing Perineal Complications After Abdominoperineal Resection

Start date: April 3, 2020
Phase:
Study type: Observational

Abdominoperineal resection leaves an empty space to be filled by mesh or musculocutaneus flap. Several studies have reported over 30% morbidity with perineal wound healing after abdominoperineal resection. Preoperative radiotherapy is a strong predictor for perineal complications. Musculocutaneus flaps and use of biological mesh seem to minimize perineal morbidity. The role of omentoplasty at APR is controversial. Previous studies on synthetic mesh repair on perineum are almost lacking.

NCT ID: NCT04323722 Recruiting - Rectal Cancer Clinical Trials

Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer

MESORECT-VV
Start date: September 8, 2020
Phase: N/A
Study type: Interventional

This trial is assessing how Bladder filling variations and thus mesorectal movements are less when radiotherapy treatment is received with an empty bladder in rectal cancer

NCT ID: NCT04316078 Completed - Gastric Cancer Clinical Trials

A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies

Start date: March 15, 2020
Phase: N/A
Study type: Interventional

A randomized control trial to evaluate the feasibility of implementing a patient educational platform (PEP) for patients with gastrointestinal malignancies undergoing active chemotherapy treatment.

NCT ID: NCT04316013 Recruiting - Clinical trials for Non Small Cell Lung Cancer

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial

Start date: July 31, 2020
Phase: Phase 3
Study type: Interventional

VAPOR-C is a randomised study of the impact of IV versus inhaled anaesthesia (propofol versus sevoflurane) and lidocaine versus no lidocaine on duration of disease free survival inpatients with either colorectal or non small cell lung cancer.

NCT ID: NCT04296240 Recruiting - Rectal Cancer Clinical Trials

Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer

Start date: March 1, 2019
Phase: Phase 2
Study type: Interventional

This study is designed to test the Safety and efficacy of induction and individualized neoadjuvant chemotherapy based on oxaliplatin combined with fluorouracil for MRF-negative, moderate-risk and initially resectable middle and low rectal cancer.

NCT ID: NCT04293835 Completed - Rectal Cancer Clinical Trials

Sigmoid Take-off, New Rectum Definition

Start date: June 1, 2019
Phase:
Study type: Observational

The diversity of definitions for the rectosigmoid junction is becoming a major obstacle to the standardization of optimal treatment of rectal cancers. The aim of this study was to determine the average height of the sigmoid take-off and its association with individual factors. Patients diagnosed with rectal and sigmoid colon cancer in our center from January 2010 to December 2018 were retrospectively enrolled in the cancer group. The results of 200 controls without colorectal disease were also reviewed (normal group). The distance of different landmarks and margins of cancer from the anal verge were retrieved from computed tomography (CT), magnetic resonance imaging (MRI), and endoscopy findings.